NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE236719 Query DataSets for GSE236719
Status Public on Jun 21, 2024
Title Synthetic essentiality of thymine DNA glycosylase in p53-deficient cancer [ChIP-seq]
Organisms Homo sapiens; Mus musculus
Experiment type Genome binding/occupancy profiling by high throughput sequencing
Summary Thymine DNA Glycosylase (TDG) is a versatile protein involved in DNA mismatch repair, DNA demethylation, and transcriptional regulation. Here, we identify TDG as a synthetic essential effector in p53-deficient tumours. We found that deletion of TDG inhibits cell proliferation specifically in p53-deficient cancer cells. Using a genetically engineered mouse model of lung adenocarcinoma (LUAD), we demonstrate that depletion of TDG suppresses tumour growth in the p53-deficient context. Notably, A novel and selective inhibitor developed to disrupt the DNA binding activity of TDG exhibits therapeutic efficacy against p53-deficient tumours in both cellular and xenograft models. Mechanistically, TDG coordinates with p53 to orchestrate the transcription of RNA helicase DHX9, which functions to eliminate dsRNA. Depletion of TDG in p53-deficient cells results in the downregulation of DHX9 and aberrant cytoplasmic double-strand (dsRNA) accumulation derived from Alu elements, subsequently activating the RIG-I/MDA5-MAVS mediated antiviral response. Moreover, single-cell RNA-sequencing analysis revealed the depletion of TDG in p53-deficient tumours facilitates the recruitment of tumour-infiltrating lymphocytes. We observed that TDG inhibition combined with immune checkpoint blockade (ICB) achieved a strong synergistic anti-tumour effect in p53-deficient tumours. This study highlights the function of TDG in maintaining p53-deficient tumour growth and provides an alternative therapeutic target for p53-deficient cancers.
 
Overall design Chromatin immunoprecipitation DNA-sequencing (ChIP-seq) for TDG and p53 as well as CUT&Tag for P300 and the histone modifications H3K9me3, H3K4me3 in B16 cells.
 
Contributor(s) Zhou J, Shao Z
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Jul 06, 2023
Last update date Jun 22, 2024
Contact name Zhenyu Shao
Organization name Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
Department Center for Excellence in Molecular Cell Science
Street address Yueyang Road 320
City shanghai
State/province --- Select a state ---
ZIP/Postal code 200031
Country China
 
Platforms (2)
GPL24247 Illumina NovaSeq 6000 (Mus musculus)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (9)
GSM7574436 input ChIP-Seq
GSM7574437 IgG ChIP-Seq
GSM7574438 HA_control ChIP-Seq
This SubSeries is part of SuperSeries:
GSE236728 Synthetic essentiality of thymine DNA glycosylase in p53-deficient cancer
Relations
BioProject PRJNA992082

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE236719_DMSOvsC271_peaks.narrowPeak.gz 13.9 Kb (ftp)(http) NARROWPEAK
GSE236719_RAW.tar 1.2 Gb (http)(custom) TAR (of BW, NARROWPEAK)
SRA Run SelectorHelp
Raw data are available in SRA
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap